Ardelyx
ARDX
$6.42
Share price
1.74%
Change (1 day)
43.95%
Change (1 year)
Categories
Ardelyx (ARDX) - P/B ratio
P/B ratio as of April 2024 : 8.96
According to Ardelyx's latest financial reports the company has a price-to-book ratio of 8.96.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ardelyx - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 8.63 | 58.79% |
| 2022-12-31 | 5.43 | 261.96% |
| 2021-12-31 | 1.50 | -68.74% |
| 2020-12-31 | 4.80 | 34.47% |
| 2019-12-31 | 3.57 | 269.59% |
| 2018-12-31 | 0.9663 | -57.09% |
| 2017-12-31 | 2.25 | -35.24% |
| 2016-12-31 | 3.48 | -19.51% |
| 2015-12-31 | 4.32 | -25.34% |
| 2014-12-31 | 5.79 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.81 | -46.34% | 🇺🇸 USA |
 Amgen AMGN | 23.2 | 159.48% | 🇺🇸 USA |
 Sanofi SNY | 1.49 | -83.34% | 🇫🇷 France |
 AstraZeneca AZN | 6.21 | -30.60% | 🇬🇧 UK |
 OPKO Health
OPK | 0.6322 | -92.94% | 🇺🇸 USA |